Stock ZIM ZIMMER BIOMET HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Zimmer Biomet Holdings, Inc. Börse Stuttgart

Equities

ZIM

US98956P1021

Market Closed - Börse Stuttgart
Other stock markets
 15:14:11 28/06/2024 BST 		5-day change 1st Jan Change
100.3 EUR -0.10% Intraday chart for Zimmer Biomet Holdings, Inc. -0.30% -8.28%
06-20 Zimmer Biomet Holdings, Inc. Appoints Devdatt Kurdikar to its Board of Directors CI
06-12 Zimmer Biomet Enters Co-Marketing Deal With RevelAi Health MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Ex-dividend day
FA
Zimmer Biomet Holdings, Inc. Appoints Devdatt Kurdikar to its Board of Directors
CI
THINK Surgical Enters Distribution Agreement with Zimmer Biomet
AQ
RevelAi Health and Zimmer Biomet Announce Exclusive Multi-Year, Co-Marketing Agreement to Advance Value Based Care and Health Equity through AI-Powered Technology
AQ
Zimmer Biomet Enters Co-Marketing Deal With RevelAi Health
MT
Zimmer Biomet Enters Distribution Agreement with THINK Surgical to Offer TMINI Miniature Handheld Robotic System for Total Knee Arthroplasty
AQ
RevelAi Health and Zimmer Biomet Announce Exclusive Multi-Year Co-Marketing Agreement to Advance Value-Based Care and Health Equity through AI-Powered Technology
PR
RevelAi Health and Zimmer Biomet Holdings, Inc. Announce Exclusive Multi-Year Co-Marketing Agreement to Advance Value-Based Care and Health Equity Through AI-Powered Technology
CI
Transcript : Zimmer Biomet Holdings, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-11-2024 08:40 AM
Zimmer Biomet Enters Distribution Agreement with THINK Surgical to Offer TMINI® Miniature Handheld Robotic System for Total Knee Arthroplasty
PR
Zimmer Biomet Enters Distribution Agreement with THINK Surgical to Offer TMINI Miniature Handheld Robotic System for Total Knee Arthroplasty
CI
Osteal Therapeutics, Inc. announced that it has received $50 million in funding from Zimmer Biomet Holdings, Inc., Johnson & Johnson Innovation - JJDC, Inc., HM Capital Management, LLC, GIDEON STRATEGIC PARTNERS LLC and other investors
CI
Zimmer Biomet Holdings Insider Sold Shares Worth $1,474,582, According to a Recent SEC Filing
MT
Zimmer Biomet to Present at the Goldman Sachs 45th Annual Healthcare Conference
PR
Zimmer Biomet's Limited Exposure to High-Growth Markets Spurs Revenue Concerns, UBS Says
MT
Barclays Adjusts Price Target on Zimmer Biomet to $125 From $130
MT
Barclays Adjusts Price Target on Zimmer Biomet Holdings to $125 From $130
MT
Zimmer Biomet Outlines Growth Strategy Through 2027; Board Approves $2 Billion Stock Buyback
MT
Zimmer Biomet Outlines Strategy to Deliver Above Market Growth at 2024 Investor Day
PR
Zimmer Biomet Holdings, Inc. announces an Equity Buyback for $2,000 million worth of its shares.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ZBH Stock
  4. ZIM Stock
  5. News Zimmer Biomet Holdings, Inc.